comparemela.com

Latest Breaking News On - Ram selvaraju - Page 5 : comparemela.com

Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2023.

United-states
America
Marc-goodman
Mark-jacobson
Myles-minter-william-blair
Vikram-purohit
Piper-sandler
Joe-thome-cowen
Charles-duncan
Myles-minter
Yatin-suneja-guggenheim
Vikram-purohit-morgan-stanley

Phase 3 Trial in Progress of New Ichthyosis Treatment

Phase 3 Trial in Progress of New Ichthyosis Treatment

Italy
Germany
Canada
United-states
Switzerland
New-jersey
France
Swiss
American
Ram-selvaraju
Raghuram-selvaraju
Boobalan-pachaiyappan

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2022 Earnings Call Transcript

Operator: Good day and thank you for standing by and welcome to Arcadia Biosciences Q4 2022 Financial Results and Business Highlights Conference Call.

United-states
Canada
American
Ram-selvaraju
Mitchell-kapoor
Los-angeles
Stan-jacot
Instagram
Facebook
American-heart-association
Nasdaq
Arcadia-biosciences-inc

H.C. Wainwright Reaffirms Their Buy Rating on Urogen Pharma (URGN)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Urogen Pharma (URGN – Research Report) today and set a price target of $2.

New-york
United-states
Schoenberg-mark
Asher-holzer
Ram-selvaraju
Urogen-pharma
Oramed-pharm
Urogen-pharma-ltd
Research-report
Rockwell-med
Moderate-buy
Gen-pharma

H.C. Wainwright Reaffirms Their Buy Rating on Verona Pharma (VRNA)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $3.

United-kingdom
London
City-of
Canaccord-genuity
Verona-pharma
Oramed-pharm
Michael-ja-walker
Ram-selvaraju
Verona-pharma-plc
Research-report
Rockwell-med
Strong-buy

vimarsana © 2020. All Rights Reserved.